Venrock  
上个世纪30年代，Laurance Rockefeller（1910-2004）就开始对Eastern航空和McDonnell航空公司身后的企业家Eddie Rickenbacker和James “Mac” McDonnell进行投资，从而开创了美国早期企业的风险投资先例。Lanrance在John D. Rockefeller, Jr的六个子女中排行老四。在过去的20年中，他作为以科技发展为未来方向的年轻企业的风险投资人而受到认可，他所关注的投资领域包括电子、高温物理、合成材料、光学、激光、数据处理、热粒子学以及核能等。

1969年，Laurance和他的兄弟成立了Venrock公司，扩大风险资本投资项目的领域并使之专业化。自那时起，Venrock就发展成为美国最顶级的风险投资公司，并在帕罗奥图（Palo Alto）、纽约和剑桥（Cambridge）拥有办事处。Venrock的企业家在癌症、抗感染、自动免疫治疗、动力半导体和数字领域取得了巨大的成就，同时还推动了信息技术基础设施的建设，并引领了网络广告的发展。最近公司又在可替代发电方式、医药信息技术创新和社交网络等领域成绩斐然。Venrock所投资公司包括苹果电脑、Athenahealth、Centocor、Check Point软件、Double Click、Gilead科技、Idec制药、Illumina、Intel、Millennium制药、Sirna医疗、StrataCom和Vontu等。

通过对科技、医药和能源等领域的关注，Venrock继承了Rockefeller近百年来向企业家进行投资并建立成功、可持久发展企业的传统；公司的长期投资回报率使之成为最顶尖的风投公司之一，并能够长久拥有卓越的业绩。

In the 1930’s, Laurance Rockefeller (1910-2004) pioneered early-stage venture capital in the United States by investing in Eddie Rickenbacker and James “Mac” McDonnell, the entrepreneurs behind Eastern Airlines and McDonnell Aircraft. Laurance was the fourth of six children of John D. Rockefeller, Jr. Over the next 20 years, he became well known as an investor of risk capital in young enterprises whose future was based on scientific and technological developments, including the fields of electronics, high temperature physics, composite materials, optics, lasers, data processing, thermionics and nuclear power.

In 1969, Laurance and his siblings formed Venrock in order to expand and “professionalize” this venture capital investment program. Since then, Venrock has developed into one of the country’s leading venture capital firms with offices in Palo Alto, New York and Cambridge. Venrock entrepreneurs have charted new advancements in cancer, anti-infective and auto-immune therapies, powered semiconductors and the digital era, secured our information technology infrastructure, pioneered on-line advertising, and most recently, are generating power through alternative means, fostering innovation in healthcare IT, and harnessing the social web. Portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom and Vontu.

With a current focus on technology, healthcare and energy, Venrock continues the eight-decade Rockefeller tradition of funding entrepreneurs and establishing successful, enduring companies, and the firm’s investment returns place it among the top tier venture capital firms that have achieved consistently superior performance.